Our solutions and developments

Healthcare AI: Medical Decision Layer

Innovative products and technologies for investors and partners

1

Concept: "Virtual Therapist" and AI Medical Decision Layer

D'Elite Medical (@delite_medical_bot) is a digital gateway to medicine: an AI-first triage and second opinion service that transforms a chaotic user complaint into a clear action plan in minutes. For the client, this saves time and reduces anxiety; for the healthcare system, it provides a manageable flow of requests; and for investors, it provides a scalable AI medical decision layer with clear unit economics for mass-scale scenarios.

The product addresses the most common and time-consuming step: "What's wrong with me and where to go next." The user receives a structured pre-visit briefing: symptoms and context, risk indicators, urgency level, likely scenarios, and personalized routing (self-help, scheduled visit, urgent care).

Positioning for the user and controllers

  • We do not declare: "We diagnose and treat."
  • We declare: "We help you understand what's happening and what to do next" — information support, routing, and preparation for a doctor's visit.
2

AI Triage Engine: core of the product

Focus on the applied decision-making engine based on the urgency and context of a case, already implemented in a working Telegram scenario.

⚡ Multi-step questionnaire (gender, age, weight, height, chronic conditions) and triage by urgency
🏥 Client ID verification and managed consultation login – ready for corporate/B2B environments
📎 Working with case materials: up to 5 files (JPG/JPEG/PNG/BMP/TIFF/PDF) and up to 5 text messages
🧑‍⚕️ Asynchronous attachment processing and final AI second opinion with next step routing

Key insight: AI doesn't replace doctors—it scales them, allowing them to serve approximately 2–5 times more patients with the same amount of time.

3

Market and monetization

According to industry estimates, telemedicine could grow from approximately $113 billion to ~$441 billion by 2034, while the AI segment in telemedicine could grow from ~$26 billion to ~$176 billion; compound growth rates (CAGRs) are often quoted in the range of ~23–36%. This is one of the fastest-growing markets; drivers include a shortage of physicians, chronic diseases, rising healthcare costs, patient convenience, and cost-per-patient reductions thanks to AI.

Health in Numbers: Actual User Demand

A cross-section of over 5,000 requests to D'Elite Medical reveals the true structure of demand: approximately 50% are for acute respiratory conditions, approximately 30% are for gastrointestinal issues, approximately 10% are for musculoskeletal issues, and approximately 7% are for psychological conditions (anxiety, stress, aggression). These data confirm a consistent focus on "everyday" but common medical scenarios where speed and accessibility of care are critical.

A global comparison strengthens the investment case: telemedicine has already become a standard for millions of users, and the mental health and remote support segment remains one of the fastest-growing. This creates long-term demand for AI-based initial assessment and routing services.

Why is the model attractive to investors?

  • Repeatable request scenarios create a scalable base for improving the quality of recommendations and automation.
  • Hybrid B2C + B2B monetization reduces dependence on a single channel and accelerates revenue generation.
  • The product improves partners' key business metrics: initial response time, cost per request, and conversion to target path.
  • Regulatory-safe positioning as a second opinion and routing reduces the legal risks of early scaling.

Monetization models

The monetization model has already been implemented in production: paid subscription scenarios and a payment system are running in the existing product, confirming effective demand and generating a validated, repeatable revenue stream.

  • B2C: subscription ($1–20/month), payment per consultation.
  • B2B: clinics, insurance companies, HR, and corporate medicine—savings by reducing the workload of doctors.
  • A powerful combination for market entry: B2B SaaS for organizations and convenient service access for patients.
4

Competitors, niche and regulation

Among the benchmarks: B2C — Ada Health, K Health, Doctronic (AI urgent care); historically — Babylon (market model, project closed). B2B — Teladoc (tens of millions of ecosystem users), Counsel Health (AI + physician).

Regulatory risk (EU, US FDA, different regulations by country) makes the initial positioning of a second opinion + recommendation system, rather than a "diagnosis system," mitigating legal and reputational burden in the early stages.

5

MVP Roadmap

Phase 1 Basic outline

User scenario, questionnaire, AI analysis and basic structured response.

Phase 2 Triage and analysis

Strengthening triage, handling downloaded analyses, security policies, and response quality.

Phase 3 Scoring and history

Scoring urgency and confidence, patient case history, improving UX.

Phase 4 B2B and doctor's office

B2B API, doctor's office, integration with medical information systems and partner systems.

6

Assessing the prospects

Pros

  • A large and rapidly growing market, a pressing concern for frontline providers and patients.
  • A fast path to MVP based on existing AI components and scenarios.

Risks

  • Regulation, responsibility for recommendations, user trust, competition between major players.
Stage

Current stage

Phase 2 (traction + product optimization)

D'Elite Medical (@delite_medical_bot) is already operational: client ID verification, questionnaire, complaint collection, up to 5 files and up to 5 texts, followed by an AI second opinion. The current focus is on triage accuracy, response speed, and preparation for B2B scaling.

The product is already in production via the Telegram bot @delite_medical_bot. Current functionality includes: client ID verification, language selection, a structured questionnaire, complaint and case file collection (up to 5 files and 5 text messages), launching an AI assessment via the "Get AI therapist opinion" button, asynchronous attachment processing, and delivering a final second opinion in chat. Currently, the team is improving the clinical accuracy of triage across key demand categories (acute respiratory viral infections, gastrointestinal tract, musculoskeletal system, psychological conditions), reducing time-to-response, and preparing for B2B scaling (clinics, insurance companies, corporate healthcare). Key KPIs for this stage include routing accuracy, response speed, case completion rate, repeat usage, and user trust.

Want to see the product in a user-friendly format?

Go to the D'Elite Medical promo page